Company intelligence / Profile preview
Giuliani
Milan, MI, Italygiulianipharma.com ↗
- Ownership
- Private
- Employees
- ~289
- Development stage
- Commercial
01
Overview
Giuliani markets proprietary drugs for gastrointestinal and dermatological conditions such as ulcerative colitis and Crohn’s disease. Its R&D pipeline includes new chemical entities and biotechnological agents targeting inflammatory and autoimmune diseases. The company also develops supplements for hair loss prevention with a focus on microbiome science. It has a long-standing reputation in Italy for quality-driven innovation in consumer health as well as prescription pharmaceuticals.
- Therapeutic areas
- GastroenterologyDermatologyImmunology
- Modalities
- Small moleculeBiologic (biotechnological products)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Giuliani.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Giuliani.